Advertisement
UK markets close in 4 hours 24 minutes

  • FTSE 100

    8,117.49
    +38.63 (+0.48%)
     

  • FTSE 250

    19,828.23
    +226.25 (+1.15%)
     

  • AIM

    755.42
    +2.30 (+0.31%)
     

  • GBP/EUR

    1.1662
    +0.0006 (+0.05%)
     

  • GBP/USD

    1.2514
    +0.0003 (+0.03%)
     

  • Bitcoin GBP

    51,240.37
    +513.74 (+1.01%)
     

  • CMC Crypto 200

    1,385.22
    -11.31 (-0.81%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CRUDE OIL

    84.10
    +0.53 (+0.63%)
     

  • GOLD FUTURES

    2,360.20
    +17.70 (+0.76%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,048.99
    +131.71 (+0.74%)
     

  • CAC 40

    8,040.53
    +23.88 (+0.30%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Is GN STORE NORD (GNNDY) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. GN STORE NORD (GNNDY) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? One simple way to answer this question is to take a look at the year-to-date performance of GNNDY and the rest of the Medical group's stocks.

GN STORE NORD is one of 895 individual stocks in the Medical sector. Collectively, these companies sit at #1 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.

The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. GNNDY is currently sporting a Zacks Rank of #1 (Strong Buy).

Within the past quarter, the Zacks Consensus Estimate for GNNDY's full-year earnings has moved 0.08% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.

ADVERTISEMENT

According to our latest data, GNNDY has moved about 1.03% on a year-to-date basis. Meanwhile, the Medical sector has returned an average of -13.13% on a year-to-date basis. This means that GN STORE NORD is performing better than its sector in terms of year-to-date returns.

To break things down more, GNNDY belongs to the Medical - Products industry, a group that includes 82 individual companies and currently sits at #47 in the Zacks Industry Rank. This group has lost an average of 15.58% so far this year, so GNNDY is performing better in this area.

Investors with an interest in Medical stocks should continue to track GNNDY. The stock will be looking to continue its solid performance.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
GN STORE NORD (GNNDY) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.